News

ZIM LABORATORIES LIMITED will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. Trading window for the company`s securities will be closed from Thursday, October 1, 2026, to Friday, November 6, 2026, inclusive, in accordance with SEBI regulations and the company’s code of conduct.

Zim Laboratories Limited informed the Bombay Stock Exchange and National Stock Exchange that MUFG Intime India Private Limited, formerly Link Intime India Private Limited, confirmed compliance under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Zim Laboratories Limited informed the BSE Limited and National Stock Exchange of India Limited that it will close the trading window for dealing with securities of the company for designated persons and their immediate relatives from October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s code of conduct, reopening 48 hours after the declaration of financial results for the quarter ended September 30, 2026.

ZIM LABORATORIES LIMITED announced the incorporation of its wholly owned subsidiary, ZIM Laboratories SpA, in Santiago, Republic of Chile, on September 9, 2026. The subsidiary, incorporated with a cash consideration, will focus on expanding and developing the company’s pharmaceutical business in the Latin America (LATAM) region, with ZIM Laboratories Limited subscribing to 14,100 shares at a face value of Chilean Pesos 1,000 each, resulting in 100% shareholding.

Net Loss of Zim Laboratories reported to Rs 4.02 crore in the quarter ended June 2026 as against net loss of Rs 1.87 crore during the previous quarter ended June 2025. Sales rose 31.24% to Rs 94.18 crore in the quarter ended June 2026 as against Rs 71.76 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales94.1871.76 31 OPM %2.605.94 - PBDT-0.202.43 PL PBT-5.57-2.43 -129 NP-4.02-1.87 -115 Powered by Capital Market - Live News